Jochen Sven Utikal, MD

نقل شده توسط

	همهٔ موارد	از 2020
نقل‌‏قول‌‏ها	44698	25988
شاخص h	84	72
شاخص i10	282	245

6000

3000

1500

4500

2007200820092010201120122013201420152016201720182019202020212022202320242025157 366 743 929 1004 973 1092 1278 1513 1944 2185 2636 3261 4141 5175 5189 5197 5421 823

دسترسی عمومی

مشاهدهٔ همه

۱۲۵ مقاله

۲۳ مقاله

در دسترس

در دسترس نیست

براساس دستورات هزینه انتشار

نویسندگان مشترک

Prof. Dr. Christoffer GebhardtUniversitätsklinikum Hamburg-Eppendorf (UKE)ایمیل تأیید شده در uke.de
Thomas EigentlerDepartment of Dermatology, Venereology and Allergology, Charité Berlinایمیل تأیید شده در charite.de
James LarkinRoyal Marsden Hospital / Institute of Cancer Research, London, UKایمیل تأیید شده در rmh.nhs.uk
Peter Herseyایمیل تأیید شده در sydney.edu.au
Nimet MaheraliHarvard Universityایمیل تأیید شده در fas.harvard.edu
Matthias StadtfeldWeill Cornell Medicineایمیل تأیید شده در med.cornell.edu
Katrin ArnoldRoche (previously Harvard Medical School, DKFZ Heidelberg)ایمیل تأیید شده در roche.com
Levi GarrawayAssociate Professor of Medicine, Harvard Medical Schoolایمیل تأیید شده در dfci.harvard.edu
Eliezer Van AllenDana-Farber Cancer Instituteایمیل تأیید شده در dfci.harvard.edu
Thomas TütingDepartment of Dermatology, University Hospital Magdeburg, Germanyایمیل تأیید شده در med.ovgu.de
Wei XieSchool of Life Sciences, Tsinghua University, Beijing, Chinaایمیل تأیید شده در tsinghua.edu.cn
Roland HoubenDermatology Würzburgایمیل تأیید شده در ukw.de
Paolo A. AsciertoIstituto Nazionale Tumori Fondazione "G. Pascale", Napoli, Italyایمیل تأیید شده در istitutotumori.na.it
Tim Ahfeldtایمیل تأیید شده در harvard.edu
Matthias GoebelerUniversity of Würzburg, University of Heidelberg, University of Giessen, University of Münsterایمیل تأیید شده در klinik.uni-wuerzburg.de
Xinlai ChengFrankfurt Universityایمیل تأیید شده در pharmchem.uni-frankfurt.de
Ralf MrowkaProfessor at Friedrich-Schiller-University Jena, Faculty of Medicineایمیل تأیید شده در med.uni-jena.de
Michael HolzelInstitute of Experimental Oncology, University Hospital Bonn, Germany. Twitter: @IEO_HolzelLabایمیل تأیید شده در ukb.uni-bonn.de
Stefan B. EichmüllerGerman Cancer Research Center (DKFZ)ایمیل تأیید شده در dkfz.de
Ralf LudwigProfessor of Dermatology, University of Lübeckایمیل تأیید شده در uksh.de

دنبال کردن

Jochen Sven Utikal, MD

Professor for Dermatooncology, German Cancer Research Center and University Medical Center Mannheim

ایمیل تأیید شده در dkfz.de

Melanoma Stem Cells Skin Cancer Dermatology


عنوان به‌ترتیب نقل قول‌ها به‌ترتیب سال به‌ترتیب عنوان	نقل شده توسط نقل شده توسط	سال
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma‏ EM Van Allen, D Miao, B Schilling, SA Shukla, C Blank, L Zimmer, ...‏ Science 350 (6257), 207-211, 2015‏	2914	2015
Improved survival with MEK inhibition in BRAF-mutated melanoma‏ KT Flaherty, C Robert, P Hersey, P Nathan, C Garbe, M Milhem, ...‏ New England Journal of Medicine 367 (2), 107-114, 2012‏	2674	2012
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer‏ U Sahin, E Derhovanessian, M Miller, BP Kloke, P Simon, M Löwer, ...‏ Nature 547 (7662), 222-226, 2017‏	2451	2017
Induced pluripotent stem cells generated without viral integration‏ M Stadtfeld, M Nagaya, J Utikal, G Weir, K Hochedlinger‏ Science 322 (5903), 945-949, 2008‏	2341	2008
Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution‏ N Maherali, R Sridharan, W Xie, J Utikal, S Eminli, K Arnold, M Stadtfeld, ...‏ Cell stem cell 1 (1), 55-70, 2007‏	2284	2007
Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma‏ GV Long, D Stroyakovskiy, H Gogas, E Levchenko, F de Braud, J Larkin, ...‏ New England Journal of Medicine 371 (20), 1877-1888, 2014‏	2119	2014
Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial‏ GV Long, D Stroyakovskiy, H Gogas, E Levchenko, F De Braud, J Larkin, ...‏ The Lancet 386 (9992), 444-451, 2015‏	1623	2015
Immortalization eliminates a roadblock during cellular reprogramming into iPS cells‏ J Utikal, JM Polo, M Stadtfeld, N Maherali, W Kulalert, RM Walsh, A Khalil, ...‏ Nature 460 (7259), 1145-1148, 2009‏	1071	2009
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma‏ U Sahin, P Oehm, E Derhovanessian, RA Jabulowsky, M Vormehr, ...‏ Nature 585 (7823), 107-112, 2020‏	821	2020
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma‏ D Liu, B Schilling, D Liu, A Sucker, E Livingstone, L Jerby-Arnon, ...‏ Nature medicine 25 (12), 1916-1927, 2019‏	789	2019
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study‏ GV Long, KT Flaherty, D Stroyakovskiy, H Gogas, E Levchenko, ...‏ Annals of Oncology 28 (7), 1631-1639, 2017‏	786	2017
A high-efficiency system for the generation and study of human induced pluripotent stem cells‏ N Maherali, T Ahfeldt, A Rigamonti, J Utikal, C Cowan, K Hochedlinger‏ Cell stem cell 3 (3), 340-345, 2008‏	762	2008
Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression‏ C Groth, X Hu, R Weber, V Fleming, P Altevogt, J Utikal, V Umansky‏ British journal of cancer 120 (1), 16-25, 2019‏	750	2019
Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy‏ L Hofmann, A Forschner, C Loquai, SM Goldinger, L Zimmer, S Ugurel, ...‏ European journal of cancer 60, 190-209, 2016‏	709	2016
Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy‏ L Zimmer, SM Goldinger, L Hofmann, C Loquai, S Ugurel, I Thomas, ...‏ European journal of cancer 60, 210-225, 2016‏	605	2016
Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task‏ TJ Brinker, A Hekler, AH Enk, J Klode, A Hauschild, C Berking, B Schilling, ...‏ European Journal of Cancer 113, 47-54, 2019‏	532	2019
Myeloid-derived suppressor cells hinder the anti-cancer activity of immune checkpoint inhibitors‏ R Weber, V Fleming, X Hu, V Nagibin, C Groth, P Altevogt, J Utikal, ...‏ Frontiers in immunology 9, 1310, 2018‏	525	2018
Skin cancer classification using convolutional neural networks: systematic review‏ TJ Brinker, A Hekler, JS Utikal, N Grabe, D Schadendorf, J Klode, ...‏ Journal of medical Internet research 20 (10), e11936, 2018‏	503	2018
Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression‏ S Eminli, J Utikal, K Arnold, R Jaenisch, K Hochedlinger‏ Stem cells 26 (10), 2467-2474, 2008‏	501	2008
Targeting myeloid-derived suppressor cells to bypass tumor-induced immunosuppression‏ V Fleming, X Hu, R Weber, V Nagibin, C Groth, P Altevogt, J Utikal, ...‏ Frontiers in immunology 9, 398, 2018‏	467	2018

سیستم در حال حاضر قادر به انجام عملکرد نیست. بعداً دوباره امتحان کنید.

مقاله‌ها 1–20

نقل‌قول‌ها در سال

نقل‌قول تکراری

نقل‌قول‌های ادغام شده

افزودن نویسنده‌های همکارنویسندگان مشترک

دنبال کردن

نقل شده توسط

نویسندگان مشترک